DIN 02522438 — GLASSIA 1000 MG
GLASSIA is a solution of Alpha1-Proteinase Inhibitor marketed by TAKEDA CANADA INC. The full Alpha1-Proteinase Inhibitor monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02522438
- Brand name
- GLASSIA
- Active ingredient
- Alpha1-Proteinase Inhibitor
- Strength
- 1000 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Plasma-derived protein replacement (Alpha-1 proteinase inhibitor augmentation therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Alpha1-Proteinase Inhibitor products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02204606 | PROLASTIN-C | 1000 MG | POWDER FOR SOLUTION | GRIFOLS THERAPEUTICS LLC | MARKETED |